Clinical Trial Site

Pittsburgh, Pennsylvania 15232

3 studies enrolling now · 18 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), ANCA-Associated Vasculitis, Acute Hepatic Porphyria, Acute Intermittent Porphyria (AIP), Advanced Hepatocellular Carcinoma, Cerebral Amyloid Angiopathy, Dermatomyositis, Familial Amyloidotic Cardiomyopathy (FAC), Genetic Disease, Hemophilia A, Hemophilia B, Hepatic Porphyrias

Studies at this site

• Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty — Recruiting now
• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma — Recruiting now
• A Prospective Sub-Study of the Global Hypophosphatasia Registry — Recruiting now
• A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis — Running, not enrolling
• A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer — Running, not enrolling
• BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) — Running, not enrolling
• APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) — Completed
• Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B — Completed
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed
• Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia — Stopped early
• Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery — Stopped early
• A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation — Completed
• A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients — Completed
• INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP — Stopped early
• DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis — Completed